Companies › INFU

INFUSYSTEM HLDGS INC (INFU)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001337013 · EDGAR filings · Updated 2026-07-28

INFUSYSTEM HLDGS INC (INFU) has reported institutional ownership of 69.8%, with 96 institutional managers holding positions valued at $130.3M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Filings this week (2)

• 2026-07-28 — SCHEDULE 13G filed
• 2026-07-28 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-05-19 — Insider transaction reported (Form 4)
• 2026-05-19 — Insider transaction reported (Form 4)
• 2026-05-19 — Insider transaction reported (Form 4)
• 2026-05-19 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INFUSYSTEM HLDGS INC has 96 institutional holders and institutional ownership of 69.8%.

Insider activity

Insiders reported 20 transactions (6 buys, 1 sells) across 11 reporting insiders, with a net reported value of $40.4K.

Data flags from SEC filings

Related companies

CVRX INC (CVRX) · NEUMORA THERAPEUTICS INC. (NMRA) · ELEDON PHARMACEUTICALS INC (ELDN) · VOYAGER THERAPEUTICS INC (VYGR) · QUANTERIX CORP (QTRX) · INNOVAGE HLDG CORP (INNV)